ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) for AMERISOURCEBERGEN CORPORATION
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare prompt pay discount exclusion, including legislation to ensure appropriate reimbursement for drugs and biologics under Medicare Part B by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's Average Sales Price (ASP). Sequestration, generally Medicare Part B, including proposals to create an international pricing index and establish a competitive acquisition program Medicare Part D, including removal of safe harbor protection for drug rebates Prescription drug pricing, value, and transparency, generally
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN E IRIZARRY | — |
| VINCENT A. ROBERTI, SR. | — |
Pharmacy PHA
Issues related to drug pricing and transparency, generally. Issues related to the pharmaceutical supply chain and stockpiling Issues related to COVID vaccine distribution
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN E IRIZARRY | — |
| VINCENT A. ROBERTI, SR. | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.